PE20010316A1 - GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS - Google Patents

GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS

Info

Publication number
PE20010316A1
PE20010316A1 PE2000000446A PE0004462000A PE20010316A1 PE 20010316 A1 PE20010316 A1 PE 20010316A1 PE 2000000446 A PE2000000446 A PE 2000000446A PE 0004462000 A PE0004462000 A PE 0004462000A PE 20010316 A1 PE20010316 A1 PE 20010316A1
Authority
PE
Peru
Prior art keywords
polypeptide
intracellularis
lawsonia
refers
sequence
Prior art date
Application number
PE2000000446A
Other languages
English (en)
Inventor
Michael Panaccio
Everett Lee Rosey
Detlef Hasse
Robert Gerard Ankenbauer
Meri Sinistaj
Jim Parsons
Original Assignee
Pfizer Prod Inc
Agriculture Victoria Serv Pty
Pig Res And Dev Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc, Agriculture Victoria Serv Pty, Pig Res And Dev Corp filed Critical Pfizer Prod Inc
Publication of PE20010316A1 publication Critical patent/PE20010316A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

SE REFIERE A UN POLIPEPTIDO INMUNOGENICO AISLADO O RECOMBINANTE CARACTERIZADO PORQUE TIENE UNA REACCION CRUZADA CON UN EPITOPE DE CELULA B O CELULA T DE UN POLIPEPTIDO LAWSONIA SPP FlgE DE PREFERENCIA L. INTRACELLULARIS, SE CARACTERIZA POR PROVOCAR LA PRODUCCION DE ANTICUERPOS, CONFERIR UNA RESPUESTA INMUNOLOGICA PROTECTORA EN UN ANIMAL, PORCINO, AVE; INDUCIR INMUNIDAD HUMORAL; ES SELECCIONADO DE: a)UN PEPTIDO, OLIGOPEPTIDO, POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS QUE TIENE AL MENOS 60% DE IDENTIDAD DE LA SECUENCIA No ID SEC:1 DE 502 AMINOACIDOS O LA SECUENCIA DE AMINOACIDOS CODIFICADA POR LA SECUENCIA DE NUCLEOTIDOS QUE CODIFICA FlgE DE pALK11 (ATCC 207156); b)UN HOMOLOGO, ANALOGO, DERIVADO QUE IMITA A UN EPITOPE DE CELULA B O T DE UN POLIPEPTIDO DE LAWSONIA SPP. SE REFIERE TAMBIEN A UNA VACUNA QUE COMPRENDE ADEMAS OTRO COMPONENTE INMUNOGENICO QUE COMPRENDE UN PEPTIDO O PROTEINA DE L. INTRACELLULARIS ANTIGENICA DE PREFERENCIA OmPh, SodC, HEMOLISINA, AUTOLISINA; TAMBIEN SE REFIERE A UN VECTOR QUE COMPRENDE UN ACIDO NUCLEICO CON UNA SECUENCIA QUE CODIFICA AL POLIPEPTIDO; UN ACIDO NUCLEICO AISLADO QUE CODIFICA AL POLIPEPTIDO; UN PLASMIDO pALK11. EL POLIPEPTIDO CODIFICADO DE UN GEN DERIVADO DE LAWSONIA PUEDE SER UTIL PARA EL TRATAMIENTO DE ENFERMEDAD INTESTINAL EN ANIMALES Y PAJAROS
PE2000000446A 1999-05-13 2000-05-12 GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS PE20010316A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13397399P 1999-05-13 1999-05-13

Publications (1)

Publication Number Publication Date
PE20010316A1 true PE20010316A1 (es) 2001-03-15

Family

ID=22461178

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000446A PE20010316A1 (es) 1999-05-13 2000-05-12 GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS

Country Status (9)

Country Link
EP (1) EP1181315A4 (es)
JP (1) JP2003516113A (es)
AU (1) AU771376B2 (es)
BR (1) BR0011294A (es)
CA (1) CA2372098A1 (es)
MX (1) MXPA01011669A (es)
NZ (1) NZ515331A (es)
PE (1) PE20010316A1 (es)
WO (1) WO2000069904A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605696B1 (en) 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
ATE330013T1 (de) 2000-12-20 2006-07-15 Intervet Int Bv Lawsonia intracellularis impfstoff
EP1664100B1 (en) * 2003-09-12 2009-12-02 Intervet International BV Lawsonia intracellularis subunit vaccine
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
CN114712392B (zh) * 2022-05-16 2022-11-25 西部医美生物科技成都有限公司双流医疗分公司 来自自体血液分离的免疫细胞制剂及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
CN1145697C (zh) * 1995-11-30 2004-04-14 维多利亚农业服务控股公司 治疗和诊断组合物

Also Published As

Publication number Publication date
CA2372098A1 (en) 2000-11-23
EP1181315A4 (en) 2002-08-14
MXPA01011669A (es) 2003-09-10
BR0011294A (pt) 2002-02-26
WO2000069904A1 (en) 2000-11-23
EP1181315A1 (en) 2002-02-27
AU771376B2 (en) 2004-03-18
NZ515331A (en) 2003-07-25
JP2003516113A (ja) 2003-05-13
AU4385900A (en) 2000-12-05

Similar Documents

Publication Publication Date Title
BR9711090A (pt) Polipept¡deo omp106 isolado ou substancialmente puro anticorpo isolado fragmento de peptideo do polipeptideo omp106 vacina composi-Æo antig-nica dna substancialmente puro processo para produzir uma resposta imune em um animal e processo para produzir um cultivar nÆo hemaglutinante de m catarrhalis a partir de uma cepa ou cultivar de m catarrhalis ha
ATE319091T1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
BR0010720A (pt) Peptìdeos de neisseria antigênicos
BRPI0412799A (pt) imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura
DE69129865T2 (de) Osteogene peptide
DE69733773D1 (de) Fas ANTIGEN-DERIVATE
PE20010316A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS
BR9710975A (pt) Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis
ATE154638T1 (de) Mutanten von interleukin-3
WO2002008716A3 (fr) Procede de criblage de peptides utilisables en immunotherapie
BR0309491A (pt) Composição de vacina, composição imunogênica, utilização de uma proteìna e7 e anticorpos neutralizantes
PE20010237A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS
PE20010238A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS
AU6961601A (en) Transport peptides among which c-terminal E<sup>rns</sup> peptide and analogues thereof
PE20010239A1 (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
NO20005081L (no) Et polypeptid som omfatter aminosyren fra et N-terminalt kolinbindende protein A trunkat, vaksine avledet derav og anvendelser derav
WO2002044202A3 (fr) Peptides immunogeniques mutes derives de r9m, polynucleotides les codant et leurs usages therapeutiques
NO20011263L (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
WO1998040497A3 (en) An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
DE69130675T2 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum
AR004191A1 (es) Polipeptidos para inducir inmunidad protectora contra la tuberculosis, molecula de adn que los codifica, un vector de expresion, una celula huesped,una composicion farmaceutica, una vacuna, una proteina de fusion, un metodo para detectar la tuberculosis y kit de diagnostico.
AR036104A1 (es) Un receptor acoplado a la proteina g, gave3

Legal Events

Date Code Title Description
FC Refusal